Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravitreous bevacizumab or intravitreous
triamcinolone acetonide are effective and safe in the treatment of uveitic macular oedema